American Pharmaceutical Partners Announces ANDA Approval for Hydralazine Hydrochloride Injection, USP

Apr 05, 2001, 01:00 ET from American Pharmaceutical Partners, Inc.

    LOS ANGELES, April 5 /PRNewswire/ -- American Pharmaceutical Partners,
 Inc. (APP) announced today that the company has received approval of an
 Abbreviated New Drug Application (ANDA) from the Food and Drug Administration
 (FDA) for Hydralazine Hydrochloride Injection, a drug used to manage
 hypertension.
     (Photo:  http://www.newscom.com/cgi-bin/prnh/20010403/APPLOGO )
     According to IMS, a market research firm, U.S. sales of Hydralazine were
 approximately $12.5 million in 2000.
     American Pharmaceutical Partners, Inc, is a privately held integrated
 pharmaceutical company with over 800 employees.  APP is one of the leading
 manufacturers and marketers of injectable pharmaceuticals in the United States
 with facilities in Los Angeles, California; Schaumburg, Illinois, Melrose
 Park, Illinois, Grand Island, New York and Toronto, Canada.  For more
 information on the Company, visit APP's web site at www.appdrugs.com .
 
 

SOURCE American Pharmaceutical Partners, Inc.
    LOS ANGELES, April 5 /PRNewswire/ -- American Pharmaceutical Partners,
 Inc. (APP) announced today that the company has received approval of an
 Abbreviated New Drug Application (ANDA) from the Food and Drug Administration
 (FDA) for Hydralazine Hydrochloride Injection, a drug used to manage
 hypertension.
     (Photo:  http://www.newscom.com/cgi-bin/prnh/20010403/APPLOGO )
     According to IMS, a market research firm, U.S. sales of Hydralazine were
 approximately $12.5 million in 2000.
     American Pharmaceutical Partners, Inc, is a privately held integrated
 pharmaceutical company with over 800 employees.  APP is one of the leading
 manufacturers and marketers of injectable pharmaceuticals in the United States
 with facilities in Los Angeles, California; Schaumburg, Illinois, Melrose
 Park, Illinois, Grand Island, New York and Toronto, Canada.  For more
 information on the Company, visit APP's web site at www.appdrugs.com .
 
 SOURCE  American Pharmaceutical Partners, Inc.